Related Experiment Video
Updated: May 5, 2026

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
Published on: December 5, 2025
The role of magnesium sulfate in acute asthma: does route of administration make a difference?
1Noah Ark Children's Hospital for Wales, Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Cardiff, Wales, UK.
Purpose Of Review:
The role of magnesium sulfate (MgSO4) in the treatment of acute asthma is not clear. Four recent systematic reviews suggest a limited role of intravenous (i.v.) and inhaled nebulized treatment. The purpose of this review is to summarize the current literature, focus on two recent large multicenter randomized controlled trials, and discuss future research directions.
Recent Findings:
The Magnesium Nebulized Trial In Children (MAGNETIC) trial has shown little benefit to routine use of nebulized MgSO4 in children with acute asthma, but there may be a benefit in those with severe exacerbations and a shorter duration of symptoms. The 3Mg trial has shown no role for nebulized MgSO4 in adults and, at best a limited role for i.v. MgSO4 in only the most severe exacerbations. This is the only study with direct comparison of nebulized and i.v. MgSO4.
Summary:
MgSO4 has a role in severe exacerbations of acute asthma and there is no evidence of benefit outside this clinical situation. Both nebulized and i.v. treatments are well tolerated and inexpensive. In adults, the most effective route of administration is i.v. There are no direct comparison studies in children. Further research should focus on more severe exacerbations.
Insights
Magnesium sulfate (MgSO4) offers limited benefit for acute asthma, primarily aiding severe exacerbations. Intravenous (i.v.) administration is more effective in adults, with future research focusing on severe cases.
Area of Science:
- Pulmonology
- Emergency Medicine
- Pharmacology
Background:
- The efficacy of magnesium sulfate (MgSO4) in acute asthma treatment remains debated.
- Previous systematic reviews indicate a restricted role for both intravenous (i.v.) and inhaled nebulized MgSO4.
Purpose of the Study:
- To synthesize current literature on MgSO4 for acute asthma.
- To analyze findings from two major multicenter randomized controlled trials.
- To identify future research avenues for MgSO4 in asthma management.
Main Methods:
- Review of recent systematic reviews and two large multicenter randomized controlled trials (MAGNETIC and 3Mg).
- Analysis of data comparing nebulized and i.v. MgSO4 administration routes.
- Focus on patient subgroups, including children and adults with varying asthma severity.
Main Results:
- The MAGNETIC trial found minimal benefit of nebulized MgSO4 in children, except possibly in severe, short-duration exacerbations.
- The 3Mg trial demonstrated no benefit of nebulized MgSO4 in adults and a limited role for i.v. MgSO4 in the most severe cases.
- Intravenous (i.v.) MgSO4 showed a potential benefit in severe adult asthma exacerbations.
Conclusions:
- Magnesium sulfate (MgSO4) is indicated for severe acute asthma exacerbations; its use in milder cases lacks evidence.
- Both i.v. and nebulized MgSO4 are well-tolerated and cost-effective treatments.
- Intravenous administration is preferred in adults, while further research is needed for pediatric severe exacerbations.
Related Concept Videos
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Dosage Interval and Administration Route: Determination Methods

